National guidelines recommend that primary care providers discuss the risks and benefits of prostate cancer screening with their pa-tients but give little guidance on how to fit such a complex discussion into a busy clinic encounter. The authors propose a process-oriented approach (Ask-Tell-Ask) that promotes tai-lored conversations and value-based recommendations. The Ask-Tell-Ask approach includes diagnosing a patient’s informa-tional needs, providing targeted education based on those needs, and making a shared decision about testing. This time-efficient model emphasizes the provider’s role as an interactive guide rather than a one-way supplier of information. Although there is no way to make these discussions simple, this stream-lined st...
Prostate cancer screening is an ever-changing field because the benefits of using PSA as a screening...
BackgroundAs prostate cancer (PCa) screening decisions often occur in outpatient primary care, a bri...
Prostate-specific antigen (PSA) screening for prostate cancer remains a controversial topic, particu...
Since 2012, multiple new guidelines have been issued advising changes in screening for prostate canc...
BackgroundShared decision making improves value-concordant decision-making around prostate cancer sc...
Abstract Background Professional medical organizations recommend individualized patient decision mak...
BackgroundWe know little about patient-physician communication during visits to discuss diagnosis an...
Introduction and aims: Professional societies recommend that the decision to screen for prostate can...
PURPOSE The efficacy of prostate cancer screening is uncertain, and professional organizations recom...
Introduction: Although the US Preventive Services Task Force recommends against routine prostate can...
This Viewpoint discusses the feasibility of shared decision making among primary care physicians and...
In 2010, an estimated 24,600 Canadian men were diagnosed with prostate cancer (Canadian Cancer Socie...
Purpose: To measure the preferences and values of men newly diagnosed with prostate cancer (PC) usin...
Although the US Preventive Services Task Force recommends against routine prostate cancer screening ...
ObjectiveIdentify how patients diagnosed with prostate cancer (PCa) choose active surveillance (AS) ...
Prostate cancer screening is an ever-changing field because the benefits of using PSA as a screening...
BackgroundAs prostate cancer (PCa) screening decisions often occur in outpatient primary care, a bri...
Prostate-specific antigen (PSA) screening for prostate cancer remains a controversial topic, particu...
Since 2012, multiple new guidelines have been issued advising changes in screening for prostate canc...
BackgroundShared decision making improves value-concordant decision-making around prostate cancer sc...
Abstract Background Professional medical organizations recommend individualized patient decision mak...
BackgroundWe know little about patient-physician communication during visits to discuss diagnosis an...
Introduction and aims: Professional societies recommend that the decision to screen for prostate can...
PURPOSE The efficacy of prostate cancer screening is uncertain, and professional organizations recom...
Introduction: Although the US Preventive Services Task Force recommends against routine prostate can...
This Viewpoint discusses the feasibility of shared decision making among primary care physicians and...
In 2010, an estimated 24,600 Canadian men were diagnosed with prostate cancer (Canadian Cancer Socie...
Purpose: To measure the preferences and values of men newly diagnosed with prostate cancer (PC) usin...
Although the US Preventive Services Task Force recommends against routine prostate cancer screening ...
ObjectiveIdentify how patients diagnosed with prostate cancer (PCa) choose active surveillance (AS) ...
Prostate cancer screening is an ever-changing field because the benefits of using PSA as a screening...
BackgroundAs prostate cancer (PCa) screening decisions often occur in outpatient primary care, a bri...
Prostate-specific antigen (PSA) screening for prostate cancer remains a controversial topic, particu...